PRIONRX SCIENCE Trademark

Trademark Overview

On Monday, March 1, 2021, a trademark application was filed for PRIONRX SCIENCE with the United States Patent and Trademark Office. The USPTO has given the PRIONRX SCIENCE trademark a serial number of 90552063. The federal status of this trademark filing is REGISTERED as of Tuesday, September 20, 2022. This trademark is owned by Amprion, Inc.. The PRIONRX SCIENCE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services
prionrx science

General Information

Serial Number90552063
Word MarkPRIONRX SCIENCE
Filing DateMonday, March 1, 2021
Status700 - REGISTERED
Status DateTuesday, September 20, 2022
Registration Number6853528
Registration DateTuesday, September 20, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 16, 2021

Trademark Statements

Pseudo MarkAMPRION RX SCIENCE
Disclaimer with Predetermined Text"SCIENCE"
Goods and ServicesPharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, May 29, 2021
Primary Code042
First Use Anywhere DateMonday, June 20, 2022
First Use In Commerce DateMonday, June 20, 2022

Trademark Owner History

Party NameAmprion, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105
Party NameAmprion, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105
Party NameAmprion, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105

Trademark Events

Event DateEvent Description
Tuesday, September 20, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 20, 2022REGISTERED-PRINCIPAL REGISTER
Friday, August 19, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, August 18, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 9, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 13, 2022USE AMENDMENT FILED
Tuesday, August 9, 2022SOU EXTENSION 1 GRANTED
Monday, July 11, 2022SOU EXTENSION 1 FILED
Saturday, August 6, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 19, 2022NOTICE OF REVIVAL - E-MAILED
Wednesday, July 13, 2022EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, July 13, 2022PETITION TO REVIVE-GRANTED
Wednesday, July 13, 2022TEAS PETITION TO REVIVE RECEIVED
Wednesday, July 13, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, January 11, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 16, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 8, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 6, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 6, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 20, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 20, 2021NON-FINAL ACTION E-MAILED
Monday, September 20, 2021NON-FINAL ACTION WRITTEN
Friday, September 17, 2021ASSIGNED TO EXAMINER
Saturday, May 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 4, 2021NEW APPLICATION ENTERED IN TRAM

Related Keywords

science prionrx services development drug pharmaceutical